查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1719247

菸鹼醯胺市場－全球產業規模、佔有率、趨勢、機會及預測（按銷售管道、最終用途、地區和競爭細分，2020-2030 年）

Nicotinamide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球菸鹼醯胺市場價值為 6.2474 億美元，預計到 2030 年將達到 10.9534 億美元，複合年成長率為 6.61%。菸鹼醯胺，也稱為菸鹼醯胺，是維生素 B3 的水溶性形式，在代謝功能和細胞修復中發揮著至關重要的作用。它在藥品、食品和化妝品領域的廣泛適用性使其成為各種消費者健康和保健領域的關鍵成分。人們越來越意識到它在皮膚護理、發炎控制和代謝健康方面的益處，這推動了它在治療和生活方式相關應用中的採用。新興市場對健康和個人護理支出的需求不斷增加，進一步推動了菸鹼醯胺市場的上升趨勢。然而，如果不有效解決原料依賴和監管審查等挑戰，可能會影響長期成長。

市場概覽
預測期 2026-2030
2024年市場規模 6.2474億美元
2030年市場規模 10.9534億美元
2025-2030 年複合年成長率 6.61%
成長最快的領域 直接的
最大的市場 亞太地區

關鍵市場促進因素

製藥業的成長

主要市場挑戰

原物料價格波動

主要市場趨勢

膳食補充劑行業的成長

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球菸鹼醯胺市場的影響

第5章：全球菸鹼醯胺市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按銷售管道（直接、間接）
    • 依最終用途（藥品、化妝品和個人護理、食品和飲料、動物飼料、化學物質）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美菸鹼醯胺市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲菸鹼醯胺市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太菸鹼醯胺市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲菸鹼醯胺市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲菸鹼醯胺市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：全球菸鹼醯胺市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Nebula Health Care
  • Suchem Laboratory
  • Western Drugs Limited
  • Roopa industries limited
  • SV Labs Pvt. Ltd.
  • Veer Chemie & Aromatics pvt ltd.
  • Optimus Drugs Pvt. Ltd
  • NIGAM FINECHEM PVT. LTD
  • Ishita Drugs & Industries Ltd
  • Anhui Redpont Biotechnology Co., Ltd

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 28767

The Global Nicotinamide Market was valued at USD 624.74 million in 2024 and is expected to reach USD 1095.34 million by 2030, growing at a CAGR of 6.61%. Nicotinamide, also known as niacinamide, is a water-soluble form of vitamin B3 that plays a vital role in metabolic function and cellular repair. Its wide applicability across pharmaceutical, dietary, and cosmetic products positions it as a critical ingredient in various consumer health and wellness segments. Growing awareness of its benefits in skin care, inflammation control, and metabolic health is fueling its adoption across both therapeutic and lifestyle-related applications. Increasing demand from emerging markets, where health and personal care spending is on the rise, further contributes to the upward trajectory of the nicotinamide market. However, challenges such as raw material dependency and regulatory scrutiny may impact long-term growth if not effectively addressed.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 624.74 Million
Market Size 2030USD 1095.34 Million
CAGR 2025-20306.61%
Fastest Growing SegmentDirect
Largest MarketAsia Pacific

Key Market Drivers

Growth in Pharmaceutical Industry

The growing demand from the global pharmaceutical industry is a primary driver propelling the nicotinamide market. With the global healthcare sector generating more than USD 4 trillion annually-USD 850 billion from pharmaceuticals and biotechnology alone-nicotinamide's role in therapeutic formulations is expanding rapidly. It is widely used to treat niacin deficiency disorders, support dermatological therapies, and enhance metabolic health. Recent developments, such as Zhejiang University's co-crystallization of Ticagrelor with Nicotinamide to enhance drug solubility, underscore the compound's value in improving pharmaceutical formulations. As global pharmaceutical innovation continues to focus on solubility, efficacy, and patient outcomes, the incorporation of nicotinamide is expected to increase further across prescription and over-the-counter product categories.

Key Market Challenges

Fluctuating Raw Material Prices

Volatility in raw material prices is a key challenge for the nicotinamide market. The compound is primarily synthesized from nicotine, which is extracted from tobacco-a crop subject to variable supply conditions and geopolitical influences. Fluctuations in raw material availability or pricing can disrupt production stability and increase operational costs. These pressures are particularly impactful in regions where raw material sourcing is heavily reliant on imports. Rising sustainability standards and the need for consistent, cost-effective manufacturing practices place additional strain on producers, especially those operating in price-sensitive markets. As a result, manufacturers must continuously monitor and adapt to raw material market dynamics to ensure competitiveness.

Key Market Trends

Growth in the Dietary Supplement Sector

The dietary supplement sector is emerging as a major growth avenue for nicotinamide. With increasing consumer interest in preventive healthcare, wellness, and anti-aging, demand for nicotinamide-based supplements is on the rise. Notably, derivatives like Nicotinamide Riboside (NR), which boosts NAD+ levels in cells, are gaining traction for their potential anti-aging and metabolic benefits. This interest extends beyond general health, with pharmaceutical research exploring NR's applications in areas such as neurological health and energy metabolism. As consumers seek functional ingredients with clinically proven benefits, nicotinamide's presence in the supplement market continues to strengthen, supported by a growing body of scientific evidence and shifting consumer health priorities.

Key Market Players

  • Nebula Health Care
  • Suchem Laboratory
  • Western Drugs Limited
  • Roopa Industries Limited
  • S.V. Labs Pvt. Ltd.
  • Veer Chemie & Aromatics Pvt Ltd.
  • Optimus Drugs Pvt. Ltd
  • NIGAM FINECHEM PVT. LTD
  • Ishita Drugs & Industries Ltd
  • Anhui Redpont Biotechnology Co., Ltd

Report Scope:

In this report, the Global Nicotinamide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nicotinamide Market, By Sales Channel:

  • Direct
  • Indirect

Nicotinamide Market, By End Use:

  • Pharmaceuticals
  • Cosmetics & Personal Care
  • Food & Beverages
  • Animal Feed
  • Chemicals

Nicotinamide Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nicotinamide Market.

Available Customizations:

Global Nicotinamide Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Nicotinamide Market

5. Global Nicotinamide Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Pharmaceuticals, Cosmetics & Personal Care, Food & Beverages, Animal Feed, Chemicals)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Nicotinamide Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Nicotinamide Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Nicotinamide Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Nicotinamide Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Nicotinamide Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Nicotinamide Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Nicotinamide Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Nicotinamide Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Nicotinamide Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Nicotinamide Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Nicotinamide Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Nicotinamide Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Nicotinamide Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Nicotinamide Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Nicotinamide Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Nicotinamide Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Nicotinamide Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Nicotinamide Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Nicotinamide Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Nicotinamide Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Nicotinamide Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Nicotinamide Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Nicotinamide Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Nicotinamide Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Nicotinamide Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Nebula Health Care
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Suchem Laboratory
  • 15.3. Western Drugs Limited
  • 15.4. Roopa industries limited
  • 15.5. S.V. Labs Pvt. Ltd.
  • 15.6. Veer Chemie & Aromatics pvt ltd.
  • 15.7. Optimus Drugs Pvt. Ltd
  • 15.8. NIGAM FINECHEM PVT. LTD
  • 15.9. Ishita Drugs & Industries Ltd
  • 15.10. Anhui Redpont Biotechnology Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer